Assessing the Presence of Abnormal Regulation of Cortisol Secretion by Membrane Hormone Receptors: In Vivo and In Vitro Studies in Patients with Functioning and Non-functioning Adrenal Adenoma

Abstract

Regulation of cortisol secretion by aberrant hormone receptors may play a role in the pathogenesis of ACTH-independent Cushing’s syndrome. In this study, the topic was evaluated by combining in vivo and in vitro approaches. Cortisol responses to various stimuli (standard meal, GnRH + TRH, cisapride, vasopressin, glucagon) were assessed in 6 patients with clinical or subclinical adrenal Cushing’s syndrome, and non-functioning adrenal adenoma in two cases. Abnormal responses were observed in three patients with Cushing’s syndrome; one patient showed a gastric inhibitory polypeptide (GIP)-dependent cortisol rise after meal, together with responses after GnRH and cisapride; the second patient showed an LH-dependent cortisol response to GnRH, and in the third cortisol rose after cisapride. The pattern of receptor expression performed by RT-PCR showed that while GIP-R was only expressed in tumor from the responsive patient, 5-hydroxytryptamine type 4 receptor and LH-R were also present in normal adrenal tissues and tissues from non-responsive patients. Interestingly, an activating mutation of Gsα gene was identified in one of these tumors. Therefore, cortisol responses to agents operating via Gs protein coupled receptors (in one case associated with Gsα mutation) were found in Cushing’s patients, while these responses were absent in the others. The finding of receptor expression in normal and non-responsive tumors suggests that different mechanisms are probably involved in inducing in vivo cortisol responses.

Key words

Cushing’s syndrome · Adrenal mass · GIP receptor · Gsα gene mutation · Incidentaloma

References

• 1 Patten J L, Johns D R, Valle D, Eil C, Gruppuso P A, Steele G, Smallwood P M, Levine M A. Mutation in the gene encoding the stimulatory G protein of adenylate cyclase in Albright’s hereditary osteodystrophy.  N Engl J Med. 1990;  322 1412-1419
• 2 Kirschner L S, Carney J A, Pack S D, Taymans S E, Giatzakis C, Cho Y S, Cho-Chung , Stratakis C A. Mutations of the gene encoding the protein kinase A type-I-alpha regulatory subunit in patients with the Carney Complex.  Nat Genet. 2000;  26 89-92
• 3 Groussin L, Jullian E, Perlemoine K, Louvel A, Leheup B, Luton J P, Bertagna X, Bertherat J. Mutations of the PRKAR1A gene in Cushing’s syndrome due to sporadic primary pigmented nodular adrenocortical disease.  J Clin Endocrinol Metab. 2002;  87 4324-4329
• 4 Lacroix A, Bolté E, Tremblay J, Dupré J, Poitras P, Fournier H, Garon J, Garrel D, Bayard F, Taifeller R, Flanagan R J, Hamet P. Gastric inhibitory polypeptide-dependent cortisol hypersecretion. A new cause of Cushing’s syndrome.  N Engl J Med. 1992;  327 974-980.
• 5 Reznik Y, Allali-Zerah V, Chayvialle J A, Leroyer R, Leymarie P, Travert G, Lebrethon M, Budi I, Balliere A, Mahoudeau J. Food-dependent Cushing’s syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide.  N Engl J Med. 1992;  327 981-986
• 6 Lacroix A, Tremblay J, Rousseau G, Bouvier M, Hamet P. Propranolol therapy for ectopic βadrenergic receptors in adrenal Cushing’s syndrome.  N Engl J Med. 1997;  337 1429-1434
• 7 Lacroix A, Tremblay J, Touyz R M, Deng L Y, Lariviere R, Cusson J R, Schiffrin E J, Hamet P. Abnormal adrenal and vascular responses to vasopressin mediated by a V1-vasopressin receptor in a patient with adrenocorticotropin-independent macronodular adrenal hyperplasia, Cushing’s syndrome, and orthostatic hypotension.  J Clin Endocrinol Metab. 1997;  82 2414-2422
• 8 Willenberg H, Stratakis C, Marx C, Ehrhart-Bornstein M, Chrousos G, Bornstein S. Aberrant interleukin-1 receptors in a cortisol-secreting adenoma causing Cushing’s syndrome.  N Engl J Med. 1998;  339 27-31
• 9 Lacroix A, Hamet P, Boutin J. Leuprolide acetate therapy in luteinizing hormone-dependent Cushing’s syndrome.  N Engl J Med. 1999;  341 1577-1581
• 10 Lacroix A, N’Diaye N, Tremblay J, Hamet P. Ectopic and abnormal receptors in adrenal Cushing’s syndrome.  Endocr Rev. 2001;  22 75-110
• 11 Groussin L, Perlemoine K, Contesse V, Lefebvre H, Tabarin A, Thieblot P, Schlienger J L, Luton P, Bertagna X, Bertherat J. The ectopic expression of the gastric inhibitory polypeptide, is frequent in adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia, but rare in unilateral tumors.  J Clin Endocrinol Metab. 2002;  87 1980-1985
• 12 Feelders R A, Lamberts S WJ, Hofland L J, van Koetsveld P M, Verhoef-Post M, Themmen A PN, de Jong F H, Bonjer H J, Clark A J, van der Lely A, de Herder W W. Luteinizing hormone (LH)-responsive Cushing’s syndrome: the demonstration of LH receptor messenger ribonucleic acid in hyperplastic adrenal cells, which respond to chorionic gonadotropin and serotonin agonist in vitro. .  J Clin Endocrinol Metab. 2003;  88 230-237
• 13 Terzolo M, Osella G, Alì A, Borretta G, Cesario F, Paccotti P, Angeli A. Subclinical Cushing’s syndrome in adreanl incidentaloma.  Clin Endocrinol. 1998;  48 89-97
• 14 Varga I, Jakab C, Szücs , Patócs A, Tóth M, Kiss R, Oláz E, Rácz K. Plasma and salivary 6β-hydroxycortisol measurements for assessing adrenocortical activity in patients with adrenocortical adenomas.  Horm Metab Res. 2003;  35 421-426
• 15 Lacroix A, Mircescu H, Hamet P. Clinical evaluation of the presence of abnormal hormone receptors in adrenal Cushing’s syndrome.  The Endocrinologist. 1997;  9 9-15
• 16 Borgato S, Persani L, Romoli R, Cortelazzi D, Spada A, Beck-Peccoz P. Serum FSH levels in patients with gonadotropin secreting and nonfunctioning pituitary adenomas.  J Endocrinol Invest. 1998;  21 372-379
• 17 Tsagarakis S, Tsigos C, Vassiliou V, Tsiotra P, Pratsinis H, Kletsas D, Trivizas P, Nikou A, Mavromatis T, Sotsiou F, Raptus S, Thalassinos N. Food-dependent androgen and cortisol secretion by a gastric inhibitory polypeptide-receptor expressive adrenocortical adenoma leading to hirsutism and subclinical Cushing’s syndrome: in vivo and in vitro studies.  J Clin Endocrinol Metab. 2001;  86 583-589
• 18 Lania A, Persani L, Ballarè E, Losa M, Spada A. Constitutively active Gsα is associated with an increased phosphodiesterase activity in human growth hormone secreting adenomas.  J Clin Endocrinol Metab. 1998;  83 1624-1628
• 19 Bourdeau I, D’Amour P, Hamet P, Boutin J, Lacroix A. Aberrant membrane hormone receptor in incidentally discovered bilateral macronodular hyperplasia with subclinical Cushing’s syndrome.  J Clin Endocrinol Metab. 2001;  86 5534-5540
• 20 Noordam C, Hermus A R, Pesman G, N’Diaye N, Sweep C G, Lacroix A, Otten B J. An adolescent with food-dependent Cushing’s syndrome secondary to ectopic expression of GIP receptor in unilateral adenoma.  J Ped Endocrinol Metab. 2002;  15 853-860
• 21 Mircescu H, Jilwan J, N’Diaye N, Bourdeau I, Tremblay J, Hamet P, Lacroix A. Are ectopic or abnormal membrane receptors frequently present in adrenal Cushing’s syndrome?.  J Clin Endocrinol Metab. 2000;  85 3531-3536
• 22 Cartier D, Lihrmann I, Parmentier F, Bastard C, Bertherat J, Caron P, Kuhn J, Lacroix A, Tabarin A, Young J, Vaudry H, Lefebvre H. Overexpression of serotonin₄ receptors in cisapride-responsive adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia causing Cushing’s syndrome.  J Clin Endocrinol Metab. 2003;  88 248-254
• 23 Lefebvre H, Contesse V, Delarue C, Soubrane C, Legrand A, Kuhn J, Wolf J, Vaudry H. Effect of serotonin-4 receptor agonist zacopride on aldosterone secretion from human adrenal cortex: in vivo and in vitro studies.  J Clin Endocrinol Metab. 1993;  77 1662-1666.
• 24 Mannelli M, Ferruzzi P, Lucani P, Crescioli C, Buci L, Corona G, Serio M, Peri A. Cushing’s syndrome in a patient with bilateral macronodular hyperplasia responding to cisapride: an in vivo and in vitro study.  J Clin Endocrinol Metab. 2003;  88 4616-4622
• 25 Bugalho M J, Li X, Rao C V, Soares J, Sobrinho L G. Presence of a Gs alpha mutation in an adrenal tumor expressing LH/hCG receptors and clinically associated with Cushing’s syndrome.  Gynecol Endocrinol. 2000;  14 0-54